GENE ONLINE|News &
Opinion
Blog

SARS-CoV-2
COVID-19
Two New Coronavirus Vaccines Enter Human Trials in China
2020-04-19
COVID-19 Antibody
COVID-19 Antibody: Vir Biotechnology Partners with Samsung Biologics for Large Scale Manufacturing
2020-04-15
COVID-19 Remdesivir
Coronavirus Drugs: Studies Show Remdesivir’s Activity against Viral Enzyme
2020-04-15
COVID-19 Antibody-based Test
United States To Procure Test Kits from COVID-19 Curbing South Korea
2020-04-14
COVID-19 Remdesivir
Remdesivir’s Early Trial Data Necessitates Guarded Optimism
2020-04-12
COVID-19 Anti-parasitic
Anti-Parasitic Drug, Ivermectin Shows Anti-COVID-19 Ability in The Lab
2020-04-09
COVID-19
Amgen, Adaptive Biotechnologies Collaborate to Strengthen COVID-19 Fight
2020-04-07
COVID-19 Immune System
The Immune System’s Fight against COVID-19
2020-03-27
COVID-19
Experimental Plasma Treatment for COVID-19 Gets FDA Support
2020-03-26
R&D
Weekly Cover: Eisai to Launch “NouKNOWTM” in Japan for Regular Self-assessment of Brain Health
2020-03-26
COVID-19 Orphan Drug Designation
Gilead Requests FDA to Rescind Remdesivir’s Orphan Drug Designation
2020-03-25
COVID-19
Pharma Firm AnGes and Osaka University to Initiate Coronavirus Vaccine Testing on Animals
2020-03-25
COVID-19
India’s First Homemade COVID-19 PCR Kit Commercially Approved by Government
2020-03-24
COVID-19
QuarkBio Announces a COVID-19 Test Kit, 10 Times More Sensitive than Existing Kits
2020-03-24
COVID-19 Orphan Drug Designation
Gilead’s Remdesivir Wins FDA’s Orphan Drug Designation for COVID-19 Treatment
2020-03-24
1 … 6 7 8 9
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top